| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20060039 | HPV | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
| TVIS20059581 | HPV | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
| TVIS44012693 | HTLV-1 | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
| TVIS44025464 | HTLV-1 | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
| TVIS44048911 | HTLV-1 | ENSG00000155511.19 | protein_coding | GRIA1 | No | No | 2890 | P42261 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GRIA1 |
|---|---|
| DrugBank ID | DB00555 |
| Drug Name | Lamotrigine |
| Target ID | BE0000640 |
| UniProt ID | P42261 |
| Regulation Type | inhibitor |
| PubMed IDs | 23976856; 22564541 |
| Citations | Lapidus KA, Soleimani L, Murrough JW: Novel glutamatergic drugs for the treatment of mood disorders. Neuropsychiatr Dis Treat. 2013;9:1101-12. doi: 10.2147/NDT.S36689. Epub 2013 Aug 7.@@Leng Y, Fessler EB, Chuang DM: Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction. Int J Neuropsychopharmacol. 2013 Apr;16(3):607-20. doi: 10.1017/S1461145712000429. Epub 2012 May 8. |
| Groups | Approved; Investigational |
| Direct Classification | Dichlorobenzenes |
| SMILES | NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1 |
| Pathways | |
| PharmGKB | PA450164 |
| ChEMBL | CHEMBL741 |
